Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Total body mass and fat mass for GSH + CIT was significantly less than placebo at week 8 ( p 0.05)
Launched in the US, the product uses a proprietary science-backed blend to stimulate muscle protein synthesis
Innovators compete on clinical differentiation and market access
Efinopegdutide has been granted fast track designation by the FDA for the treatment of MASH (NCT04944992, NCT05877547) and this is the indication that the clinical development programme of this molecule will focus
Expected outcome: Potentially improved digestive comfort
In conclusion, while glutathione holds promise for potentially reducing some of the negative effects of cancer treatments, the current state of research does not provide definitive answers
US$ 20.88
US$ 27.94
US$ 22.83
